$6MStrategic, 25 November 2025
Rohto investment funds the first in-human clinical trial and access to Japan and China channels.
- Amount
- $6M
- Stage
- Strategic
- Announced
- 25 November 2025
- Lead
- Rohto Pharmaceutical
- Use of funds
- Rohto investment funds the first in-human clinical trial and access to Japan and China channels.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Australis Scientific raises A$9.3M itbrief.com.au
Australis Scientific raises A$9.3M smartcompany.com.au